All News #Library
Quality
Laurus Labs` arm gets Form 483 from FDA `adverse experience` probe
22 Jan 2025 //
CNBCTV
FDA hits drugmaker Laurus Synthesis with a 2nd rebuke
28 May 2024 //
FIERCE PHARMA
FDA Issues Untitled letter to Laurus Synthesis
22 May 2024 //
FDA
FDA slams trio of Indian drugmakers with Form 483 filings
03 Jan 2024 //
FIERCE PHARMA
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility
12 Feb 2023 //
MEDICALDIALOGUE
Laurus Labs gets Form 483 with 1 observation from USFDA
01 Nov 2022 //
BUSINESS-STANDARD

Market Place
Sourcing Support